European Archives - Page 115 of 1423 - European Medical Journal

Month in pharma news, explained

Month in pharma news, explained – November 2025

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on November 2025.

Biomarker Insights in Diabetic Incontinence from New Study - EMJ

Key Biomarker Linked to Diabetic Urinary Incontinence

A new study highlights oxidative and neuroimmune changes in diabetic urinary incontinence, identifying 4-HNE as a key biomarker differentiating diabetic and non-diabetic cases.

Unmasking Postpartum Depression

In this educational symposium from the 33rd European Congress of Psychiatry (EPA) 2025, Ramos Quiroga, Igor Emanuel, and Amaury Cantilino…

myopia

Imaging Study Reveals New Clues in Severe Short-Sightedness

PS-OCT reveals distinct scleral fibre changes in pathologic myopia, offering new clues to prevent vision loss.

sickle cell

Experts Set New Standards to Improve Sickle Cell Care

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with sickle cell disease.

ABPA Case Broadens Understanding of Rare Pleural Complications - EMJ

ABPA Case Broadens Understanding of Rare Pleural Complications

A rare case of ABPA presenting as pyopneumothorax highlights the need for early recognition of pleural complications in asthmatic patients.

Long-Acting Therapeutics for HIV

Key takeaways from the symposia. Impact of LA options on the future of treatment and prevention. Opportunities and challenges for…

4 Dec 2025

Evidence on VNS in the Modern DRE Treatment Landscape

In this interactive article, explore how drug-resistant epilepsy is linked to decreased quality of life and increased risk of morbidity and..

Clinical trial participant

ABPI: UK falling behind on clinical trial recruitment

According to the body, patient participation in industry-sponsored trials has fallen by 25% between 2022/23 and 2024/25.

Aluminum Adjuvant Imject Alum Drives Liver Fibrosis in Novel Mouse Model

High-dose aluminum adjuvant Imject Alum induces immune-mediated liver inflammation and fibrosis in mice, offering a new preclinical model that mirrors human cirrhosis biology.